The stop-work order on U.S.A.I.D.-funded research has left thousands of people with experimental drugs and devices in their ...

Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

Decentralized trials (DCTs) have been linked to increased participation rates of people of underserved populations.

Thinking about participating in a clinical trial? Here are 15 questions to ask your doctor about clinical trials for you make ...

Grants from the National Institutes of Health come with additional money for overhead. Proposed funding cuts would leave ...

A new nasal delivery method for amifostine could protect healthy tissue during pancreatic cancer radiation therapy, ...

Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...

Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...

Mild electrical brain stimulation did not further improve motor recovery in stroke survivors, according to late-breaking ...

The FDA removed previously issued draft guidance on diversity in clinical trials from its website without public notice or ...

Melvin Mann, diagnosed with chronic myeloid leukemia in 1994, participated in a clinical trial for Imatinib that extended his ...

In an interview with Applied Clinical Trials Associate Editor Don Tracy, Richard Young, CEO, CluePoints, discusses goals of the SCOPE Summit and CluePoints' evolving approach to risk detection.